Related references
Note: Only part of the references are listed.A Randomized Trial of Two Coverage Targets for Mass Treatment with Azithromycin for Trachoma
Sheila K. West et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Azithromycin Mass Treatment for Trachoma Control: Risk Factors for Non-Participation of Children in Two Treatment Rounds
Elizabeth N. Ssemanda et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Number of Years of Annual Mass Treatment With Azithromycin Needed to Control Trachoma in Hyper-endemic Communities in Tanzania
Sheila K. West et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Design and Baseline Data of a Randomized Trial to Evaluate Coverage and Frequency of Mass Treatment with Azithromycin: The Partnership for Rapid Elimination of Trachoma (PRET) in Tanzania and The Gambia
Dianne Stare et al.
OPHTHALMIC EPIDEMIOLOGY (2011)
Risk Factors for Ocular Infection with Chlamydia trachomatis in Children 6 Months following Mass Treatment in Tanzania
Luis Carlos Cajas-Monson et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Trachoma: global magnitude of a preventable cause of blindness
S. P. Mariotti et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2009)
Lack of Macrolide Resistance in Chlamydia trachomatis after Mass Azithromycin Distributions for Trachoma
Kevin Cyrus Hong et al.
EMERGING INFECTIOUS DISEASES (2009)
Risk factors for active trachoma in The Gambia
E. M. Harding-Esch et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2008)
Spatial clustering of ocular chlamydial infection over time following treatment, among households in a village in Tanzania
AT Broman et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2006)
Impact of mass distribution of azithromycin on the antibiotic susceptibilities of ocular Chlamydia trachomatis
AW Solomon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Mass treatment and the effect on the load of Chlamydia trachomatis infection in a trachoma-hyperendemic community
ES West et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
Share Paper
